Press Release: Dupixent® (dupilumab) Phase 3 Results show sustained efficacy for up to one year in children 1 to 11 years of age with eosinophilic esophagitis (EoE)

https://ift.tt/JzVhxu4

Dupixent^® (dupilumab) Phase 3 Results show sustained efficacy for up to one year in children 1 to 11 years of age with eosinophilic esophagitis (EoE)

from Sanofi - Aventis Groupe https://ift.tt/Bs10RSb
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/jFlGywJ
via IFTTT https://ift.tt/IcY7MmA

SHARE

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.

• 
• 
• 
• 
•